Pharmacokinetics and Pharmacodynamics of Landiolol Hydrochloride, an Ultra Short-acting β1-Selective Blocker, in a Dose Escalation Regimen in Healthy Male Volunteers-Reference-Cited by-同舟云学术

Pharmacokinetics and Pharmacodynamics of Landiolol Hydrochloride, an Ultra Short-acting β1-Selective Blocker, in a Dose Escalation Regimen in Healthy Male Volunteers

Published:2005 Issue:5 Volume:20 Page:337-344
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Murakami Makoto,Furuie Hidetoshi,Matsuguma Kyoko,Wanibuchi Atsuko,Kikawa Shinichi,Irie Shin

Publisher

Japanese Society for the Study of Xenobiotics

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference16 articles.

1. Atrial arrhythmias after cardiothoracic surgery;Ommen;N. Engl. J. Med.,1997

2. Hazards of postoperative atrial arrhythmias;Creswell;Ann. Thorac. Surg.,1993

3. Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery;Mathew;JAMA.,2004

4. Control of postcardiac surgical tachycardias with propranolol;Matloff;Circulation.,1968

5. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta- analysis of randomized control trials;Andrews;Circulation.,1991

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation;Pharmaceutics;2024-04-08

2. Landiolol, an intravenous β1‐selective blocker, is useful for dissociating a fusion of atrial activation via accessory pathway and atrioventricular node;Journal of Arrhythmia;2023-10-03

3. Beta-blockers in cardiac arrhythmias–Clinical pharmacologist’s point of view;Frontiers in Pharmacology;2023-01-09

4. Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension;ESC Heart Failure;2022-10-18

5. Characterization of a novel non-steroidal glucocorticoid receptor agonist optimized for topical treatment;Scientific Reports;2022-01-27